Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127443282 | 12744328 | 2 | F | 20160831 | 20160920 | 20160914 | 20160927 | EXP | US-UCBSA-2016034660 | UCB | 60.68 | YR | M | Y | 70.00000 | KG | 20160927 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127443282 | 12744328 | 1 | PS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 200 MG, EV 2 WEEKS(QOW) | Y | 125160 | 200 | MG | QOW | ||||||
| 127443282 | 12744328 | 2 | C | Oxycodone | OXYCODONE | 1 | Oral | UNK, AS NEEDED (PRN) | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127443282 | 12744328 | 1 | Rheumatoid arthritis |
| 127443282 | 12744328 | 2 | Arthralgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127443282 | 12744328 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127443282 | 12744328 | Cartilage injury | |
| 127443282 | 12744328 | Drug dose omission | |
| 127443282 | 12744328 | Osteoarthritis | |
| 127443282 | 12744328 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127443282 | 12744328 | 1 | 20160831 | 0 | ||
| 127443282 | 12744328 | 2 | 201609 | 0 |